Unituxin is specifically indicated for use in combination with granulocyte-macrophage colonystimulating factor (GM-CSF), interleukin-2 (IL-2) and 13-cis-retinoic acid (RA), for the treatment of pediatric patients If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.
Unituxin (dinutuximab) is a chimeric monoclonal antibody composed of murine variable heavy and light chain regions and the human constant region for the heavy chain IgG1 and light chain kappa. Unituxin binds to the glycolipid disialoganglioside (GD2). Dinutuximab is produced in the murine myeloma cell line, SP2/0.
Unituxin (Dinutuximab) Injection suppliers in India. Allevaire India New Delhi, INDIA.
Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.
Alleviare Life Sciences connects the buyer with the supplier who can ship Unituxin (Dinutuximab) (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. Unituxin (Dinutuximab) is manufactured by United Therapeutics Corporation.
Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
The order for Unituxin (Dinutuximab) Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Unituxin (dinutuximab) is indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2) and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy.
Verify that patients have adequate hematologic, respiratory, hepatic, and renal function prior to initiating each course of Unituxin.
Administer required premedication and hydration prior to initiation of each Unituxin infusion.
Generic Name: Dinutuximab
Approval Date: 2015
Available as (Form & Strength): Injection: 17.5 mg / 5 ml , 3.5mg/ml | Single Use Vial, Discard Unused Portion
Company Name: United Therapeutics Corporation
Please contact +91 9818274099 for Unituxin (Dinutuximab) price in India
We take guarantee of quality and delivery anywhere in the world as per the buyers requirements.
Unituxin is supplied in a carton containing one 17.5 mg/5 mL (3.5 mg/mL) single-use vial.
Store Unituxin vials under refrigeration at 2°C to 8°C until time of use.
Do not freeze or shake the vial.
Keep the vial in the outer carton in order to protect from light.
Unituxin is available.
Get In Touch
ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Unituxin (Dinutuximab) Injection on prescription and Import License in Patient’s Name only.
For foreign countries patients, Unituxin (Dinutuximab) Injection can be made available in Send your inquiry to find Unituxin (Dinutuximab) Injection in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Unituxin (Dinutuximab) Injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details